The binding affinities of the diastereoisomers of adenosine 3',5'-(cyclic)phosphorothioate, Sp-cAMP [S] and Rp-cAMP [S], for the cyclic AMP-(cAMP-)binding sites on purified and reconstituted pig heart type II cAMP-dependent protein kinase holoenzyme were determined by measuring the ability of these compounds to displace [3H]cAMP from this enzyme. Sp-cAMP[S], a cAMP agonist, displaced 50 % of the [3H]cAMP bound to the holoenzyme at a concentration 10-fold higher than that of cAMP; Rp-cAMP[S], a cAMP antagonist, required a 100-fold higher concentration relative to cAMP. Activation of the isolated holoenzyme, determined as phosphotransferase activity, was measured in the presence of the agonist and in the absence and in the presence of increasing concentrations of the antagonist. The results of fitting the activation data to sigmoid curves with a non-linear-regression program and to Hill plots by using a linearregression program showed that Rp-cAMP[S] had no effect on Vmax, increased the EC50 values for agonist activation and had no effect on the co-operativity of activation (h). A K1 value of 11 UM was determined for Rp-cAMP[S] inhibition of cAMP-induced activation of purified type II cAMP-dependent protein kinase. Electrophoresis of the holoenzyme on polyacrylamide gels under non-denaturing conditions in the presence of saturating concentrations of the diastereoisomers resulted in 100 % dissociation of the subunits with Sp-cAMP [S] and 0 % dissociation with Rp-cAMP [S]. Sp-cAMP[S], the isomer with an axial exocycic sulphur atom, binds to the holoenzyme, releases the catalytic subunit and activates the phosphotransferase activity. Rp-cAMP[S], the isomer with an equatorial exocyclic sulphur atom, binds to the holoenzyme but does not result in dissociation, and thus acts as a competitive inhibitor of phosphotransferase activity.
INTRODUCTION
The diastereoisomers of adenosine 3',5'-(cyclic)-phosphorothioate, Sp-cAMP[S] and Rp-cAMP [S] , have a sulphur substitution in one of the two exocyclic oxygen positions of cAMP. Although they differ structurally from one another only in the orientation of the sulphur atom with respect to the chiral phosphorus atom, cAMPdependent protein kinase, the target enzyme, recognizes them as different molecules. Thus the analogues have a 10-fold difference in binding affinity for the holoenzyme as measured by [3H] cAMP displacement and opposite effects on enzyme activity measured in vitro as phosphotransferase activity (De Wit et al., 1982 , 1984 and in isolated hepatocytes as glucose production (Rothermel et al., 1983 (Rothermel et al., , 1984a Dragland-Meserve et al., 1986; Marks & Parker Botelho, 1986) . Sp-cAMP [S] , which has an axial sulphur atom, binds to the holoenzyme with a 10-fold lower affinity compared with cAMP and promotes dissociation of the holoenzyme. Rp-cAMP[S] , which has an equatorial sulphur atom, binds to the holoenzyme with a 100-fold lower affinity compared with cAMP and does not promote dissociation. Thus the orientation of the exocyclic sulphur atom determines both the affinity of the analogues for the cAMP-binding sites as well as their effect on the tetrameric structure of the holoenzyme.
Previously, studies to elucidate the molecular mechanisms responsible for the differences in the kinetic properties of these diastereoisomers with regard to their interaction with cAMP-dependent protein kinase have been delayed by the lack of sufficient quantities of pure compounds. Recently, an improved procedure for synthesis of diastereometrically pure Sp-cAMP [S] and Rp-cAMP [S] has been developed (Eberle & Brzechffa, 1988) , allowing adequate amounts to be prepared for further investigation of these properties. The purpose of the present study was to determine accurate activation and inhibition constants for the analogue-enzyme interactions and to explore the mechanism by which Rp-cAMP[S] acts as a cAMP antagonist. The following experiments are described: (1) measurement of the relative binding affinities of the diastereoisomers for purified type II cAMP-dependent protein kinase; (2) determination of various kinetic parameters for RpcAMP[S] inhibition of purified and partially purified type I and type II isoenzymes from different tissues and different species; (3) determination of the degree of dissociation of cyclic nucleotide-saturated holoenzyme by non-denaturing polyacrylamide-gel electrophoresis.
EXPERIMENTAL Materials
The phosphorothioates were prepared as previously described (Baraniak et al., 1979a) with modifications to improve the yield (Eberle & Brzechffa, 1988 Isolation and purification of pig heart and bovine muscle cAMP-dependent protein kinase holoenzymes
The isolated subunits of pig heart and bovine muscle cAMP-dependent protein kinase were purified as previously described (Beavo et al., 1975; Kerlavage & Taylor, 1982) and were frozen immediately in a buffer containing 25 mM-KH2PO4, 25 mM-K2HPO4, 1 mM-EDTA and 5 mM-2-mercaptoethanol. The holoenzyme was reconstituted by mixing regulatory subunit with a slight excess (5-10 %) of catalytic subunit and dialysing exhaustively against a buffer containing 12.5 mm-K2HPO4, 12.5 mM-KH2PO4 (pH 6.1), 5 mM-2-mercaptoethanol, 2 mM-EDTA and 5 % (v/v) glycerol. After dialysis, a slurry of CM-Sepharose CL-6B resin equilibrated with the dialysis buffer was added to the holoenzyme mixture at a concentration of 2 ml of resin/ mg of excess catalytic subunit, and the mixture was dialysed exhaustively as before. After the second dialysis, the resin slurry was spun at 100 g for 10-15 s and the supernatant containing the purified holoenzyme was removed.
Equilibrium binding studies
The equilibrium binding studies were done as previously described (D0skeland & Haga, 1978; D0skeland et al., 1977 Percentage activation was measured in accordance with Cherrington et al. (1976) with the following minor modifications. In addition to the concentrations of cyclic nucleotides stated above, assay tubes contained 10 mMpotassium phosphate, pH 6.5,25 mM-magnesium acetate, 5 mM-NaF, 50 ,cM-Kemptide, 0.5-1.0,uCi of [32P]ATP plus sufficient unlabelled ATP for a final concentration of 100 AM. The assay was initiated by addition of 20 #1 of enzyme. Preparations of type I (bovine muscle) and type II (pig heart) enzyme contained 20 ,ug/ml, and preparations of type I (rabbit muscle) and type II (bovine heart) enzyme contained 2007/gg/ml. After incubation for 8 min at 30°C, the reaction was terminated in accordance with the procedure of Witt & Roskoski (1980) by pipetting a 60 ,1 portion from the 75 gl, incubation volume on to squares (2.5 cm x 2.5 cm) of Whatman P-81 chromatography paper. The paper squa-res were rinsed in deionized water (1O ml/square) twice for 20 min each time and their radioactivities counted in a scintillation counter.
Measurement of K1 values for Rp-cAMPIS] inhibition of isolated cAMP-dependent protein kinase
A Ki value for inhibition of isolated cAMP-dependent protein kinase by a cAMP antagonist can be obtained by measuring cAMP activation in the presence of several concentrations of the cAMP antagonist. If it is assumed that cAMP-dependent protein kinase activation and cAMP binding are linearly coupled processes showing positive co-operativity (Ogreid & D0skeland, 1982) , then the concentration-dependence of the activation process can be described by the following parameters (Swillens, 1983) : the maximal activity, the concentration of cAMP that gives half-maximal activity, and the degree of sensitivity of the activation process to changes in cAMP concentration. The sensitivity parameter, or the measure of co-operativity, can be adequately characterized by the Hill coefficient, which can be obtained either from a nonlinear-regression analysis of each set of activation data by using the function describing a sigmoid curve:
where x is equal to concentration of the activator, K is a constant and h is the Hill coefficient, or from the slopes of a Hill plot of these data, log[f/(1-f)] versus log [cAMP] . The value for h in eqn. (1) describes the co-operativity of the activation process using all the data points defining the sigmoid curve; the value for h (called h') calculated from the slopes of the Hill plots uses only the data points that define the linear portion of the sigmoid curve. The concentrations of cAMP required for half-maximal activation (EC50) in the presence of inhibitor are obtained from the abscissa-axis intercept of the Hill plot. The K1 value, the concentration of inhibitor required for half-maximal inhibition of cAMP-induced activation, can then be calculated from a plot of the EC50 values as a function of the inhibitor concentration. The K1 value is the product of the ordinate-axis intercept and the reciprocal of the slope of the regression line.
Non-linear-regression and linear-regression curvefitting was done with the RS/1 statistics and graphics software package from Bolt, Beranek and Newman, Cambridge, MA, U.S.A.
Standardization of K; values
The binding of cAMP to the holoenzyme is highly dependent on the concentration of the enzyme used in the assay (Baraniak et al., 1979b; Schwechheimer & Hofmann, 1977; Beavo et al., 1974 
K (cAMP) is the concentration of cAMP experimentally determined to activate the enzyme halfmaximally and K (Rp-cAMP [S] ) is the concentration of Rp-cAMP[S] experimentally determined to inhibit the cAMP-induced activation half-maximally. By conversion into thermodynamic units all the activation constants for the different isoenzymes can be related to those of cAMP measured under the same experimental conditions. Non-denaturing polyacrylamide-gel electrophoresis Polyacrylamide-gel electrophoresis was run in accordance with Laemmli (1970) Table 2 . [cAMPI (pM) cAMP-dependent protein kinase activation was measured as phosphotransferase activity as described in the Experimental section. Experimental data are shown in Fig. 2 and the experimental details are given in the legend to Fig.  2 and in the Experimental section. EC50 is the concentration of cAMP reqiuired for half-maximal activation of phosphotransferase activity. Values were obtained from the abscissa axis intercepts of Hill plots. h is the Hill coefficient derived from a non-linear-regression analysis of each set of activation data using the function describing a sigmoid curve (eqn. 1). See the Experimental section for details. Data are shown in Fig. 2 . h' is the Hill coefficient derived from the slopes of the Hill plots of the activation data. 
